— Know what they know.
Not Investment Advice

ESRX NASDAQ

Express Scripts Holding Company
1W: -6.0% 1M: -3.1% 3M: -2.4% 1Y: +24.8% 3Y: +5.9% 5Y: +36.0%
$92.33
Last traded 2018-12-21 — delisted
NASDAQ · Healthcare · Medical - Pharmaceuticals

Cash Flow Trends

Operating Cash Flow
$5.4B +8.8% ▲
5Y CAGR: +2.3%
Capital Expenditures
$267M +19.1% ▲
5Y CAGR: +10.8%
Free Cash Flow
$5.1B +10.8% ▲
5Y CAGR: +1.9%
Dividends Paid
$0 +0.0% ▲
Buybacks
$2.9B +38.1% ▲
Net Change in Cash
-$768M -603.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2013FY2014FY2015FY2016FY2017
— Operating Activities —
Net Income$1.9B$2.0B$2.5B$3.4B$4.5B
Depreciation & Amort.$2.4B$2.2B$2.4B$2.2B$1.8B
Stock-Based Comp.$165M$111M$117M$107M$100M
Change in Working Capital$775M$599M$381M-$236M$554M
Other Non-Cash Items$18M-$8M-$46M-$36M$43M
Operating Cash Flow$4.8B$4.5B$4.8B$4.9B$5.4B
— Investing Activities —
Capital Expenditures-$423M-$437M-$296M-$330M-$267M
Acquisitions (Net)$342M$2M$0$0-$3.4B
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$8M$22M$27M-$22M-$7M
Investing Cash Flow-$72M-$412M-$268M-$352M-$3.7B
— Financing Activities —
Net Debt Issuance-$1.9B-$344M$2.1B$54M$469M
Stock Repurchased-$4.1B-$4.5B-$5.5B-$4.7B-$2.9B
Dividends Paid$0$0$0$0$0
Other Financing$492M$548M$174M$15M$36M
Financing Cash Flow-$5.5B-$4.3B-$3.2B-$4.7B-$2.4B
Net Change in Cash-$802M-$159M$1.4B-$109M-$768M
Cash End of Period$2.0B$1.8B$3.2B$3.1B$2.3B
Free Cash Flow$4.3B$4.1B$4.6B$4.6B$5.1B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms